부산대학교 도서관

Elkrief, Arielle ; Hennessy, Cassandra ; Kuderer, Nicole M ; Rubinstein, Samuel M ; Wulff-Burchfield, Elizabeth ; Rosovsky, Rachel P ; Vega-Luna, Karen ; Thompson, Michael A ; Panagiotou, Orestis A ; Desai, Aakash ; Rivera, Donna R ; Khaki, Ali Raza ; Tachiki, Lisa ; Lynch, Ryan C ; Stratton, Catherine ; Elias, Rawad ; Batist, Gerald ; Kasi, Anup ; Shah, Dimpy P ; Bakouny, Ziad ; Cabal, Angelo ; Clement, Jessica ; Crowell, Jennifer ; Dixon, Becky ; Friese, Christopher R ; Fry, Stacy L ; Grover, Punita ; Gulati, Shuchi ; Gupta, Shilpa ; Hwang, Clara ; Khan, Hina ; Kim, Soo Jung ; Klein, Elizabeth J ; Labaki, Chris ; McKay, Rana R ; Nizam, Amanda ; Pennell, Nathan A ; Puc, Matthew ; Schmidt, Andrew L ; Shahrokni, Armin ; Shaya, Justin A ; Su, Christopher T ; Wall, Sarah ; Williams, Nicole ; Wise-Draper, Trisha M ; Mishra, Sanjay ; Grivas, Petros ; French, Benjamin ; Warner, Jeremy L ; Wildes, Tanya M

In The Lancet Healthy Longevity March 2022 3(3):e143-e152

Navani, Vishal ; Wells, J Connor ; Boyne, Devon J ; Cheung, Winson Y ; Brenner, Darren M ; McGregor, Bradley A ; Labaki, Chris ; Schmidt, Andrew L ; McKay, Rana R ; Meza, Luis ; Pal, Sumanta K ; Donskov, Frede ; Beuselinck, Benoit ; Otiato, Maxwell ; Ludwig, Lisa ; Powles, Thomas ; Szabados, Bernadett E ; Choueiri, Toni K ; Heng, Daniel Y C

In Clinical Genitourinary Cancer February 2023 21(1):106-106

Fu J; Department of Internal Medicine, Hematology-Oncology, Tufts Medical Center Cancer Center, Stoneham, Massachusetts.; Reid SA; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center, Nashville, Tennessee.; French B; Department of Biostatistics, Vanderbilt University, Nashville, Tennessee.; Hennessy C; Department of Biostatistics, Vanderbilt University, Nashville, Tennessee.; Hwang C; Department of Internal Medicine, Division of Hematology-Oncology, Henry Ford Cancer Institute, Detroit, Michigan.; Gatson NT; Geisinger Health System, Danville, Danville, Pennsylvania.; Department of Cancer Medicine, Division of Neuro-Oncology, Banner MD Anderson Cancer Center, Gilbert, Arizona.; Duma N; Division of Medical Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Mishra S; Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center, Nashville, Tennessee.; Nguyen R; Department of Hematology and Oncology, University of Illinois, Chicago.; Hawley JE; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York.; Now with Division of Oncology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle.; Singh SRK; Department of Internal Medicine, Division of Hematology-Oncology, Henry Ford Cancer Institute, Detroit, Michigan.; Chism DD; Thompson Cancer Survival Center, Knoxville, Tennessee.; Venepalli NK; Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill.; Warner JL; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee.; Choueiri TK; Division of Medical Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Schmidt AL; Division of Medical Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Fecher LA; Rogel Cancer Center, University of Michigan, Ann Arbor.; Girard JE; Rogel Cancer Center, University of Michigan, Ann Arbor.; Bilen MA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.; Ravindranathan D; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.; Goyal S; Department of Radiation Oncology, George Washington University, Washington, DC.; Wise-Draper TM; Department of Internal Medicine, Division of Hematology-Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio.; Park C; Department of Hematology-Oncology, University of California, Davis.; Painter CA; Count Me In, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; McGlown SM; Patient advocate.; de Lima Lopes G Jr; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, Florida.; Serrano OK; Department of Surgery, Hartford HealthCare Cancer Institute, Hartford, Connecticut.; Shah DP; Population Health Sciences, Mays Cancer Center at University of Texas Health San Antonio MD Anderson, San Antonio.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Schmidt AL; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Tucker MD; Vanderbilt University Medical Center, Nashville, Tennessee.; Bakouny Z; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Labaki C; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hsu CY; Vanderbilt University Medical Center, Nashville, Tennessee.; Shyr Y; Vanderbilt University Medical Center, Nashville, Tennessee.; Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, North Carolina.; Beer TM; Oregon Health and Science University Knight Cancer Institute, Portland.; Bijjula RR; UPMC Western Maryland, Cumberland.; Bilen MA; Winship Cancer Institute of Emory University, Atlanta, Georgia.; Connell CF; Penn State Cancer Institute, Hershey, Pennsylvania.; Dawsey SJ; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.; Faller B; Missouri Baptist Medical Center, St Louis.; Gao X; Massachusetts General Hospital, Boston.; Gartrell BA; Montefiore Einstein College of Medicine, Bronx, New York.; Gill D; Intermountain Healthcare, Salt Lake City, Utah.; Gulati S; University of Cincinnati College of Medicine, Cincinnati, Ohio.; Halabi S; Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, North Carolina.; Hwang C; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan.; Joshi M; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.; Khaki AR; University of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle.; Stanford University, Stanford, California.; Menon H; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.; Morris MJ; Memorial Sloan Kettering Cancer Center, New York, New York.; Puc M; Virtua Health Network, Marlton, New Jersey.; Russell KB; Tallahassee Memorial Healthcare, Tallahassee, Florida.; Shah NJ; Memorial Sloan Kettering Cancer Center, New York, New York.; Sharifi N; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.; Shaya J; Moores Cancer Center, University of California, San Diego.; Schweizer MT; University of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle.; Steinharter J; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Wulff-Burchfield EM; University of Kansas Medical Center, Westwood.; Xu W; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Zhu J; Penn State Cancer Institute, Hershey, Pennsylvania.; Mishra S; Vanderbilt University Medical Center, Nashville, Tennessee.; Grivas P; University of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle.; Rini BI; Vanderbilt University Medical Center, Nashville, Tennessee.; Warner JL; Vanderbilt University Medical Center, Nashville, Tennessee.; Zhang T; Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, North Carolina.; Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gupta S; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.; McKay RR; Moores Cancer Center, University of California, San Diego.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Paciotti M; Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Urology, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.; Schmidt AL; Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Ravi P; Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; McKay RR; Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, California, USA.; Trinh QD; Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Choueiri TK; Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

McGregor BA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Campbell MT; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Xie W; Dana-Farber Cancer Institute, Boston, Massachusetts.; Farah S; Dana-Farber Cancer Institute, Boston, Massachusetts.; Bilen MA; Winship Cancer Institute of Emory University, Atlanta, Georgia.; Schmidt AL; Dana-Farber Cancer Institute, Boston, Massachusetts.; Sonpavde GP; Dana-Farber Cancer Institute, Boston, Massachusetts.; Kilbridge KL; Dana-Farber Cancer Institute, Boston, Massachusetts.; Choudhury AD; Dana-Farber Cancer Institute, Boston, Massachusetts.; Mortazavi A; The Ohio State University, Columbus, Ohio.; Shah AY; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Venkatesan AM; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bubley GJ; Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Siefker-Radtke AO; The University of Texas MD Anderson Cancer Center, Houston, Texas.; McKay RR; University of California San Diego, San Diego, California.; Choueiri TK; Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Loo Gan C; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.; Huang J; Dana-Farber Cancer Institute/Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.; Pan E; University of California San Diego, La Jolla, CA, USA.; Xie W; Dana-Farber Cancer Institute/Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.; Schmidt AL; Dana-Farber Cancer Institute/Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.; Labaki C; Dana-Farber Cancer Institute/Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.; Meza L; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Bouchard G; Dana-Farber Cancer Institute/Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.; Li H; Division of Medical Oncology, Department of Internal Medicine, University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.; Jackson-Spence F; Barts Cancer Institute, Queen Mary University of London, London, UK.; Sánchez-Ruiz C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.; Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK.; Kumar SA; Division of Medical Oncology, Department of Internal Medicine, University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.; Weise N; University of California San Diego, La Jolla, CA, USA.; Hall WA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.; Rose BS; Dana-Farber Cancer Institute/Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.; Beuselinck B; University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Suarez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.; Pal SK; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Choueiri TK; Dana-Farber Cancer Institute/Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.; Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.; McKay RR; University of California San Diego, La Jolla, CA, USA. Electronic address: rmckay@health.ucsd.edu.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA.; Labaki C; Dana-Farber Cancer Institute, Boston, MA, USA.; Bakouny Z; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Hsu CY; Department of Biostatistics, Vanderbilt University, Nashville, TN, USA.; Schmidt AL; Dana-Farber Cancer Institute, Boston, MA, USA.; de Lima Lopes G Jr; Sylvester Comprehensive Cancer Center at the University of Miami, Miami, FL, USA.; Hwang C; Division of Hematology and Medical Oncology, Henry Ford Health System, Detroit, MI, USA.; Singh SRK; Division of Hematology and Medical Oncology, Henry Ford Health System, Detroit, MI, USA.; Jani C; Department of Internal Medicine, Mount Auburn Hospital, Beth Israel Lahey Health, Cambridge, MA, USA.; Weissmann LB; Department of Internal Medicine, Mount Auburn Hospital, Beth Israel Lahey Health, Cambridge, MA, USA.; Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Halabi S; Duke University Medical Center, Durham, NC, USA.; Wu U; Hartford HealthCare Cancer Institute, Hartford, CT, USA.; Berg S; Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA.; O'Connor TE; Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA.; Wise-Draper TM; University of Cincinnati Cancer Center, Cincinnati, OH, USA.; Panagiotou OA; The Warren Alpert Medical School of Brown University and Lifespan Cancer Institute, Providence, RI, USA.; Klein EJ; The Warren Alpert Medical School of Brown University and Lifespan Cancer Institute, Providence, RI, USA.; Joshi M; Penn State Cancer Institute, Hershey, PA, USA.; Yared F; Johns Hopkins University, Baltimore, MD, USA.; Dutra MS; McGill University Health Centre, Montreal, Quebec, Canada.; Gatson NTN; Geisinger Health System, Danville, Danville, PA, USA.; Blau S; Northwest Medical Specialties, PLLC, Puyallup, WA, USA.; Singh H; Medical College of Wisconsin, Milwaukee, WI, USA.; Nanchal R; Medical College of Wisconsin, Milwaukee, WI, USA.; McKay RR; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.; Nonato TK; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.; Quinn R; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.; Rubinstein SM; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Puc M; Virtua Health, Mt. Holly, NJ, USA.; Mavromatis BH; UPMC Western Maryland, MD, USA.; Vikas P; Holden Comprehensive Cancer Center, Iowa City, IA, USA.; Faller B; Missouri Baptist Medical Center Cancer Center/Heartland NCORP, St Louis, MO, USA.; Zaren HA; St. Joseph's Candler Health System, Savannah, GA, USA.; Del Prete S; Stamford Hospital, Stamford, CT, USA.; Russell K; Tallahassee Memorial Healthcare, Tallahassee, FL, USA.; Reuben DY; Medical University of South Carolina, Charleston, SC, USA.; Accordino MK; Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY, USA.; Singh H; U.S. Food and Drug Administration, Silver Spring, MD, USA.; Friese CR; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.; Mishra S; The Warren Alpert Medical School of Brown University and Lifespan Cancer Institute, Providence, RI, USA.; Rivera DR; U.S. Food and Drug Administration, Silver Spring, MD, USA.; Shyr Y; Department of Biostatistics, Vanderbilt University, Nashville, TN, USA.; Farmakiotis D; The Warren Alpert Medical School of Brown University and Lifespan Cancer Institute, Providence, RI, USA.; Warner JL; The Warren Alpert Medical School of Brown University and Lifespan Cancer Institute, Providence, RI, USA.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9918232503006676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2667-193X (Electronic) Linking ISSN: 2667193X NLM ISO Abbreviation: Lancet Reg Health Am Subsets: PubMed not MEDLINE

Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Grover P; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio.; Awosika J; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio.; Gulati S; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio.; Hsu CY; Vanderbilt University Medical Center, Nashville, Tennessee.; Alimohamed SI; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina.; Bashir B; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.; Berg S; Loyola University Medical Center, Maywood, Illinois.; Bilen MA; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Bowles D; University of Colorado, Denver.; Castellano C; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Desai A; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.; Elkrief A; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.; Eton OE; Hartford Healthcare Cancer Institute, Hartford, Connecticut.; Fecher LA; University of Michigan Rogel Cancer Center, Ann Arbor.; Flora D; St. Elizabeth Health Care, Edgewood, Kentucky.; Galsky MD; Tisch Cancer Institute, Mount Sinai, New York.; Gatti-Mays ME; Division of Medical Oncology, The Ohio State University, Columbus.; Gesenhues A; St. Elizabeth Health Care, Edgewood, Kentucky.; Glover MJ; Stanford University, Stanford, California.; Gopalakrishnan D; Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Gupta S; Cleveland Clinic, Cleveland, Ohio.; Halfdanarson TR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.; Hayes-Lattin B; Knight Cancer Institute, Oregon Health and Science University, Portland.; Hendawi M; Aurora Cancer Center, Advocate Aurora Health, Milwaukee, Wisconsin.; Hsu E; Hartford Healthcare Cancer Institute, Hartford, Connecticut.; Hwang C; Henry Ford Cancer Institute, Detroit, Michigan.; Jandarov R; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio.; Jani C; Mt. Auburn Hospital, Boston, Massachusetts.; Johnson DB; Vanderbilt University Medical Center, Nashville, Tennessee.; Joshi M; Penn State Cancer Institute, Hershey, Pennsylvania.; Khan H; Brown University and Lifespan Cancer Institute, Providence, Rhode Island.; Khan SA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York.; Knox N; Loyola University Medical Center, Maywood, Illinois.; Koshkin VS; UCSF, Helen Diller Comprehensive Cancer Center, San Francisco.; Kulkarni AA; Masonic Cancer Center, University of Minnesota, Minneapolis.; Kwon DH; UCSF, Helen Diller Comprehensive Cancer Center, San Francisco.; Matar S; Hollings Cancer Center, MUSC, Charleston.; McKay RR; Moores Cancer Center, UCSD, San Diego, California.; Mishra S; Vanderbilt University Medical Center, Nashville, Tennessee.; Moria FA; McGill University Health Centre, Montreal, Quebec, Canada.; Nizam A; Cleveland Clinic, Cleveland, Ohio.; Nock NL; Case Comprehensive Cancer Center, Department of Population and Quantitative Health Sciences, Cleveland, Ohio.; Nonato TK; Moores Cancer Center, UCSD, San Diego, California.; Panasci J; Jewish General Hospital, McGill University, Montreal, Quebec, Canada.; Pomerantz L; Penn State Cancer Institute, Hershey, Pennsylvania.; Portuguese AJ; Fred Hutchinson Cancer Research Center, Seattle, Washington.; Provenzano D; George Washington University, Washington, DC.; Puc M; Virtua Health, Marlton, New Jersey.; Rao YJ; George Washington University, Washington, DC.; Rhodes TD; Intermountain Healthcare, Salt Lake City, Utah.; Riely GJ; Memorial Sloan Kettering Cancer Center, New York.; Ripp JJ; University of Kansas Medical Center, Kansas City.; Rivera AV; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.; Ruiz-Garcia E; Instituto Nacional de Cancerologia, Mexico.; Schmidt AL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Schoenfeld AJ; Memorial Sloan Kettering Cancer Center, New York.; Schwartz GK; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York.; Shah SA; Stanford University, Stanford, California.; Shaya J; Moores Cancer Center, UCSD, San Diego, California.; Subbiah S; Stanley S. Scott Cancer Center, LSU, New Orleans, Louisiana.; Tachiki LM; Fred Hutchinson Cancer Research Center, Seattle, Washington.; Tucker MD; Vanderbilt University Medical Center, Nashville, Tennessee.; Valdez-Reyes M; Instituto Nacional de Cancerologia, Mexico.; Weissmann LB; Mt. Auburn Hospital, Boston, Massachusetts.; Wotman MT; Tisch Cancer Institute, Mount Sinai, New York.; Wulff-Burchfield EM; University of Kansas Medical Center, Kansas City.; Xie Z; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.; Yang YJ; Vanderbilt University Medical Center, Nashville, Tennessee.; Thompson MA; Aurora Cancer Center, Advocate Aurora Health, Milwaukee, Wisconsin.; Tempus Labs, Chicago, Illinois.; Shah DP; Mays Cancer Center, UT Health, San Antonio, Texas.; Warner JL; Vanderbilt University Medical Center, Nashville, Tennessee.; Shyr Y; Vanderbilt University Medical Center, Nashville, Tennessee.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Wise-Draper TM; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Groha S; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Alaiwi SA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Xu W; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Naranbhai V; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Nassar AH; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; El Zarif T; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Saliby RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Wan G; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; Rajeh A; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; Adib E; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Nuzzo PV; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genoa, Italy.; Schmidt AL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Alessi JV; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genoa, Italy.; Braun DA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Shukla SA; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Keenan TE; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.; Van Allen E; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA.; Awad MM; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genoa, Italy.; Manos M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Rahma O; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Zubiri L; Massachusetts General Hospital, Boston, MA, USA.; Villani AC; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Immunology and Inflammatory Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Fairfax B; Department of Oncology, University of Oxford, Oxford, UK.; Hammer C; Genentech, South San Francisco, CA, USA.; Khan Z; Genentech, South San Francisco, CA, USA.; Reynolds K; Harvard Medical School, Boston, MA, USA.; Division of Medical Oncology, Bartlett, Massachusetts General Hospital, Boston, MA, USA.; Semenov Y; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; Schrag D; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Kehl KL; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Freedman ML; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Choueiri TK; Harvard Medical School, Boston, MA, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Gusev A; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. alexander_gusev@dfci.harvard.edu.; Broad Institute of Harvard & MIT, Cambridge, MA, USA. alexander_gusev@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. alexander_gusev@dfci.harvard.edu.; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA. alexander_gusev@dfci.harvard.edu.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Satyanarayana G; Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Enriquez KT; Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Sun T; Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Klein EJ; The Warren Alpert Medical School of Brown University and Lifespan Cancer Institute, Providence, Rhode Island, USA.; Abidi M; University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Advani SM; Cancer Prevention and Control, Department of Oncology, Georgetown University School of Medicine, Georgetown University, Washington DC, USA.; Awosika J; University of Cincinnati Cancer Center, Cincinnati, Ohio, USA.; Bakouny Z; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Bashir B; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Berg S; Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, Illinois, USA.; Bernardes M; Memorial Sloan Kettering Cancer Center, New York City, New York, USA.; Egan PC; The Warren Alpert Medical School of Brown University and Lifespan Cancer Institute, Providence, Rhode Island, USA.; Elkrief A; McGill University Health Centre, Montreal, Quebec, Canada.; Feldman LE; University of Illinois Hospital & Health Sciences System, Chicago, Illinois, USA.; Friese CR; University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, USA.; Goel S; Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; Gomez CG; University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, USA.; Grant KL; Hartford HealthCare Cancer Institute, Hartford, Connecticut, USA.; Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; Gulati S; University of Cincinnati Cancer Center, Cincinnati, Ohio, USA.; Gupta S; Cleveland Clinic, Cleveland, Ohio, USA.; Hwang C; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan, USA.; Jain J; The University of Kansas Cancer Center, Overland Park, Kansas, USA.; Jani C; Mount Auburn Hospital, Cambridge, Massachusetts, USA.; Kaltsas A; Memorial Sloan Kettering Cancer Center, New York City, New York, USA.; Kasi A; The University of Kansas Cancer Center, Overland Park, Kansas, USA.; Khan H; The Warren Alpert Medical School of Brown University and Lifespan Cancer Institute, Providence, Rhode Island, USA.; Knox N; Stritch School of Medicine at Loyola University, Maywood, Illinois, USA.; Koshkin VS; Helen Diller Family Comprehensive Cancer Center at the University of California at San Francisco, San Francisco, California, USA.; Kwon DH; Helen Diller Family Comprehensive Cancer Center at the University of California at San Francisco, San Francisco, California, USA.; Labaki C; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Lyman GH; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; University of Washington, Seattle, Washington, USA.; McKay RR; Moores Cancer Center, University of California San Diego, La Jolla, California, USA.; McNair C; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Nagaraj G; Loma Linda University Cancer Center, Loma Linda, California, USA.; Nakasone ES; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; University of Washington, Seattle, Washington, USA.; Nguyen R; University of Illinois Hospital & Health Sciences System, Chicago, Illinois, USA.; Nonato TK; Moores Cancer Center, University of California San Diego, La Jolla, California, USA.; Olszewski AJ; The Warren Alpert Medical School of Brown University and Lifespan Cancer Institute, Providence, Rhode Island, USA.; Panagiotou OA; The Warren Alpert Medical School of Brown University and Lifespan Cancer Institute, Providence, Rhode Island, USA.; Puc M; Virtua Health, Mt. Holly, New Jersey, USA.; Razavi P; Moores Cancer Center, University of California San Diego, La Jolla, California, USA.; Robilotti EV; Memorial Sloan Kettering Cancer Center, New York City, New York, USA.; Santos-Dutra M; McGill University Health Centre, Montreal, Quebec, Canada.; Schmidt AL; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Shah DP; Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas, USA.; Shah SA; Stanford Cancer Institute at Stanford University, Stanford, California, USA.; Vieira K; The Warren Alpert Medical School of Brown University and Lifespan Cancer Institute, Providence, Rhode Island, USA.; Weissmann LB; The University of Kansas Cancer Center, Overland Park, Kansas, USA.; Wise-Draper TM; University of Cincinnati Cancer Center, Cincinnati, Ohio, USA.; Wu U; Hartford HealthCare Cancer Institute, Hartford, Connecticut, USA.; Wu JT; Stanford Cancer Institute at Stanford University, Stanford, California, USA.; Choueiri TK; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Mishra S; Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Warner JL; Vanderbilt University Medical Center, Nashville, Tennessee, USA.; French B; Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Farmakiotis D; The Warren Alpert Medical School of Brown University and Lifespan Cancer Institute, Providence, Rhode Island, USA.

Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

Li A; Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas, USA.; Kuderer NM; Advanced Cancer Research Group, Seattle, Washington, USA.; Hsu CY; Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee, USA.; Shyr Y; Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee, USA.; Warner JL; Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee, USA.; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University, Nashville, Tennessee, USA.; Shah DP; Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas, USA.; Kumar V; Section of Hematology-Oncology, University of North Carolina, Chapel Hill, North Carolina, USA.; Shah S; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.; Kulkarni AA; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.; Fu J; Hematology Oncology, Tufts Medical Center Cancer Center, Boston & Stoneham, Massachusetts, USA.; Gulati S; Division of Hematology/Oncology, University of Cincinnati, Cincinnati, Ohio, USA.; Zon RL; Division of Hematology, Brigham and Women's Hospital Boston, Boston, Massachusetts, USA.; Li M; School of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Desai A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Egan PC; Brown University and Lifespan Cancer Institute, Providence, Rhode Island, USA.; Bakouny Z; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Kc D; Hartford HealthCare Cancer Institute, Hartford, Connecticutt, USA.; Hwang C; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan, USA.; Akpan IJ; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York, USA.; McKay RR; Moores Cancer Center at the University of California, San Diego, California, USA.; Girard J; University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, USA.; Schmidt AL; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Halmos B; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.; Thompson MA; Aurora Cancer Care, Advocate Aurora Health, Milwaukee, Wisconsin, USA.; Patel JM; Beth Israel Deaconess Medical Center (BIDMC), Boston, Massachusetts, USA.; Pennell NA; Cleveland Clinic, Cleveland, Ohio, USA.; Peters S; Lausanne University Hospital, Lausanne, Switzerland.; Elshoury A; Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; de Lima Lopes G; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA.; Stover DG; Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Grivas P; University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington, USA.; Rini BI; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University, Nashville, Tennessee, USA.; Painter CA; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Mishra S; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University, Nashville, Tennessee, USA.; Connors JM; Division of Hematology, Brigham and Women's Hospital Boston, Boston, Massachusetts, USA.; Lyman GH; University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington, USA.; Rosovsky RP; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836 (Electronic) Linking ISSN: 15387836 NLM ISO Abbreviation: J Thromb Haemost Subsets: MEDLINE

Bhalla S; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Bakouny Z; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Schmidt AL; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Labaki C; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Steinharter JA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Tremblay DA; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Awad MM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Kessler AJ; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Haddad RI; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Evans M; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Busser F; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Wotman M; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Curran CR; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Zimmerman BS; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Bouchard G; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Jun T; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Nuzzo PV; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Qin Q; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Hirsch L; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Feld J; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Kelleher KM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Seidman D; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Huang HH; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Anderson-Keightly HM; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; El Zarif T; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Abou Alaiwi S; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Rosenbloom TD; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Stewart PS; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Galsky MD; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Choueiri TK; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Doroshow DB; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA. Electronic address: deborah.doroshow@mssm.edu.

Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Bakouny Z; Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Paciotti M; Division of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Urology, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.; Schmidt AL; Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lipsitz SR; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.; Choueiri TK; Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Trinh QD; Division of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Schmidt AL; Lank Centre for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA.; Tabakin AL; Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.; Singer EA; Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.; Choueiri TK; Lank Centre for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA.; McKay RR; Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101233985 Publication Model: Print Cited Medium: Internet ISSN: 1548-8756 (Electronic) Linking ISSN: 15488748 NLM ISO Abbreviation: Am Soc Clin Oncol Educ Book Subsets: MEDLINE

Schmidt AL; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Bakouny Z; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Bhalla S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Steinharter JA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Tremblay DA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Awad MM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Kessler AJ; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Haddad RI; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Evans M; Department of Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, NY 10029, USA.; Busser F; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Wotman M; Department of Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, NY 10029, USA.; Curran CR; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Zimmerman BS; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Bouchard G; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Jun T; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Nuzzo PV; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Qin Q; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Hirsch L; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Feld J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Kelleher KM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Seidman D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Huang HH; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Anderson-Keightly HM; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Abou Alaiwi S; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Rosenbloom TD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Stewart PS; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Galsky MD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.; Choueiri TK; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Doroshow DB; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA. Electronic address: deborah.doroshow@mssm.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Schmidt AL; Dana-Farber Cancer Institute, Boston, MA.; Siefker-Radtke A; University of Texas MD Anderson Cancer Center, Houston, TX.; McConkey D; Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD.; McGregor B; Dana-Farber Cancer Institute, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101233985 Publication Model: Print Cited Medium: Internet ISSN: 1548-8756 (Electronic) Linking ISSN: 15488748 NLM ISO Abbreviation: Am Soc Clin Oncol Educ Book Subsets: MEDLINE